user-generated· adoption
Wegovy pill gains 15% market share of UK weight loss drugs by Q1 2027
Within 6 months of its UK launch, the oral Wegovy pill will capture 15% of the total UK weight loss drug market, including both prescriptions and private sales. This reflects strong patient preference for non-injectable options and aggressive marketing by Novo Nordisk.
adoption · Prediction Market
- Implied probability (Yes)
- 60%
- Closes
- 2027-03-31
More adoption markets
- OpenAI Codex mobile usage exceeds desktop by Q1 2027 — 72% Yes
- OpenAI Codex mobile usage surpasses desktop within 6 months — 70% Yes
- PGA Tour Shop app downloads increase 25% YoY in 2026 — 68% Yes
- Bluesky's AT Protocol gains adoption by 3 major third-party apps by Q1 2027 — 55% Yes
- iOS 27 public release sees 20% adoption within first 6 weeks — 60% Yes
- Animal rights NGOs expand operations in Uganda by 2027 — 75% Yes
- Passive ETF inflows into SpaceX exceed $1.5 billion by October 2026 — 55% Yes
- Anthropic's enterprise AI share surpasses 30% by Q4 2026 — 75% Yes
Loading…